Showing 1 - 4 results of 4 for search 'Pekka T. Männistö', query time: 0.03s Refine Results
  1. 1
    The Catechol O-Methyltransferase Inhibitor Entacapone in the Treatment of Parkinson’s Disease: Personal Reflections on a First-in-Class Drug Development Programme 40 Years On

    The Catechol O-Methyltransferase Inhibitor Entacapone in the Treatment of Parkinson’s Disease: Personal Reflections on a First-in-Class Drug Development Programme 40 Years On by Pekka T. Männistö, Tapani Keränen, Kari J. Reinikainen, Anna Hanttu, Piero Pollesello

    Published 2024-05-01
    Get full text
    Article
  2. 2
    Catechol-O-methyltransferase (COMT) protein expression and activity after dopaminergic and noradrenergic lesions of the rat brain.

    Catechol-O-methyltransferase (COMT) protein expression and activity after dopaminergic and noradrenergic lesions of the rat brain. by Nadia Schendzielorz, Juha-Pekka Oinas, Timo T Myöhänen, Ilkka Reenilä, Atso Raasmaja, Pekka T Männistö

    Published 2013-01-01
    Get full text
    Article
  3. 3
    The beneficial effect of a prolyl oligopeptidase inhibitor, KYP-2047, on alpha-synuclein clearance and autophagy in A30P transgenic mouse

    The beneficial effect of a prolyl oligopeptidase inhibitor, KYP-2047, on alpha-synuclein clearance and autophagy in A30P transgenic mouse by Mari H. Savolainen, Christopher T. Richie, Brandon K. Harvey, Pekka T. Männistö, Kathleen A. Maguire-Zeiss, Timo T. Myöhänen

    Published 2014-08-01
    Get full text
    Article
  4. 4
    Locomotor activity and evoked dopamine release are reduced in mice overexpressing A30P-mutated human α-synuclein

    Locomotor activity and evoked dopamine release are reduced in mice overexpressing A30P-mutated human α-synuclein by Leonid Yavich, Mari Oksman, Heikki Tanila, Petri Kerokoski, Mikko Hiltunen, Thomas van Groen, Jukka Puoliväli, Pekka T. Männistö, Arturo García-Horsman, Ewen MacDonald, Konrad Beyreuther, Tobias Hartmann, Pekka Jäkälä

    Published 2005-11-01
    Get full text
    Article

Search Tools: